X

Search Results for FXI

Looking for a specific category? Check out all our product categories

Product: Chromogenix S-2302™

Product: Chromogenix S-2366™

Product: Pathway Diagnostics Human Prekallikrein Pool

Product: Pathway Diagnostics Prekallikrein Activator (PKA) Assay Standard

Product: Pathway Diagnostics Prekallikrein Activator Assay Ig Kit

Product: Pathway Diagnostics Prekallikrein Activator Assay Ig Kit

Product: Pathway Diagnostics Prekallikrein Activator Assay Kit

Product: Pathway Diagnostics Prekallikrein Activator Assay Kit

Product: Rossix FXIa Calibrator

Product: Rossix FXIa Control

Product: Technochrom® FXIII Kit

Product: Technoclone Factor XIII Deficient Plasma

Product: Technoclone Fitzgerald Trait Plasma

Product: Technofluor® FXIII Activity

Page: Activated partial thromboplastin time (aPTT)

Page: Coagulation

Page: COVID-19 & Thrombosis Research

Page: COVID-19 and Clotting Blog Post PART 2

Page: DO WE NEED TO STANDARDIZE COAGULATION NOMENCLATURE IN TODAY’S LABORATORY ENVIRONMENT?

Page: Emerging Therapeutic Targets for Hereditary Angioedema

Page: Factor XI (FXI)

Page: Factor XII (FXII)

Page: Factor XIII

Page: Factor XIII (FXIII)

Page: Fibrinolysis

Page: Hemophilia

Page: HOW TO MONITOR HEPARIN THERAPY. STILL A CONTROVERSY?

Page: Hypercoagulation During Sickle Cell Disease

Page: IVIG

Page: Kininogen

Page: Neutrophil Extracellular Traps

Page: Prekallikrein/Kallikrein

Page: Rossix

Page: Should Direct Oral Anticoagulants (DOAC) be Used in Individuals with Antiphospholipid Syndrome (aPS) vs Long Term Warfarin Treatment?

Page: The Latest Research on Direct Oral Anticoagulant (DOAC) Interferences in Testing

Page: THE NEW NOVEL ANTICOAGULANTS XI(a) and XII(a). THE CONTACT FACTOR INHIBITORS: Battling thromboembolism.

Page: Thrombin Generation Assays

Page: Thrombophilia

Page: THSNA 2020 Virtual Meeting

Page: THSNA 2022 Recap

Page: Tools for Sickle Cell Disease Research

News: AACC 2021 Press Release

News: Assays Available from Diapharma

News: Assays for IVIG Testing

News: Celebrate 35 years of Technoclone and a Special Ceveron® s100 price

News: Celebrate with DiaPharma at THSNA 2022 and learn about Ceveron® s100

News: Clot Club: Hypercoagulation During Sickle Cell Disease

News: Connect with DiaPharma at ISTH 2024

News: Contact System Cross-Talk: Tools for Investigating Contact Activation Pathway

News: Count on Diapharma for COVID-19 Related Thrombosis Research Products

News: DiaPharma is excited to bring you the latest at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo

News: Diapharma Newsletter Spring 2017

News: Explore Solutions from DiaPharma at AACC 2021

News: Factor XIII Assays to Fit Your Needs

News: Highest Quality Assays for IVIG and Albumin Safety Testing

News: Highest Quality Assays for IVIG and Albumin Safety Testing

News: Immunoglobulin Testing Assays

News: Interact LIVE with our partner Technoclone during the ISTH 2020 Congress!

News: KININ 2018 - Thank you from Diapharma

News: Learn the Latest from DiaPharma at ISTH 2021

News: NEW! PKA Standard for IVIG and Albumin Safety Testing

News: PKA Products for Reliable, Convenient IVIG and Albumin Safety Testing

News: PRECISELY BALANCED HEMOSTASIS

News: Quality Products for Anticoagulation Research

News: Reliable Assays for IVIG Testing

News: Reliable Assays for IVIG Testing

News: Sickle Cell Matters

News: Thrombin Generation Assay for Cancer Associated Thrombosis Research

News: Time-tested and Proven Chromogenic Substrates

News: Time-tested, Well-published and Proven Chromogenic Substrates

News: Visit DiaPharma at ISTH and Register to Win!

News: Why isn't this being funded?! Product Grant Opportunity from DiaPharma

News: You name it, Ceveron® s100 can do it

News: You Name It, I'll Do It - complete solutions for your hemostasis needs

News: You Name It, I'll Do It - The Ceveron® s100

News: Your Resource for COVID-19 Related Thrombosis and Fibrinolysis Products

News: YOUR SOURCE FOR HEMOPHILIA CLINICAL AND RESEARCH SOLUTIONS

Faq: What is enzyme specificity and substrate selectivity?